Home › Funds › PFM Health Sciences, LP › MDGL

PFM Health Sciences, LP position in MDGL

MADRIGAL PHARMACEUTICALS INC · Health Care

PFM Health Sciences, LP reported holding 28,876 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$14.6M, representing 1.49% of its reported portfolio and ranking #23 among its reported holdings. PFM Health Sciences, LP has disclosed MDGL holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)28.88K sh
Reported value held$14.55M
Portfolio Weight1.49%
First reportedQ1 2024
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How PFM Health Sciences, LP's MDGL position evolved

PFM Health Sciences, LP first disclosed a stake in MDGL in Q1 2024 at 29,973 shares (US$8.0M). The position peaked in Q1 2026 at 34,146 shares, worth US$17.9M. Across 6 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 28,876 shares valued at US$14.6M — a reduction of -437 shares quarter over quarter.. Notable position changes include a 370% increase in Q1 2026 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 29.97K $8.00M New
Q2 2024 29.97K $8.40M Hold
Q4 2025 7.26K $4.23M New
Q1 2026 34.15K $17.87M Add
Q2 2026 29.31K $15.74M Reduce
Q3 2026 28.88K $14.55M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MDGL and 13F data

MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 46 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), Janus Henderson Group (US$1.05B), Jupiter Topco LLC (US$1.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MDGL

All MDGL fund holders →

FAQ

How long has PFM Health Sciences, LP held MDGL?

PFM Health Sciences, LP has disclosed MDGL holdings in 6 of the last 11 reported quarters, going back to Q1 2024.

What is PFM Health Sciences, LP's current position in MDGL?

As of Q3 2026, PFM Health Sciences, LP holds 28.88K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $14.55M, representing 1.49% of its reported portfolio and ranking #23.

Has PFM Health Sciences, LP been buying or selling MDGL?

In the latest 13F filing (Q3 2026), PFM Health Sciences, LP reduced its position in MDGL. The position peaked in Q1 2026 at 34.15K shares.

Which other funds hold MDGL?

Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, Janus Henderson Group, Jupiter Topco LLC, among 46 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.